폐암 환자에서 항암요법 중 발생하는 시스플라틴신병증 = Cisplatin nephropathy in patients with lung cancer

다국어 초록 (Multilingual Abstract)

Background/Aims: This study characterized the cisplatin nephrotoxicity occurring in patients treated with chemotherapy for lung cancer. Methods: In all, 124 patients with lung cancer received cisplatin 70 mg/m2 on day 1 every three weeks for up to six cycles with preventive hydration using 3 L of 0.45% saline. Acute and chronic cisplatin nephropathy were defined as an increase in serum creatinine ≥30% at 3 weeks after each cisplatin administration and an increase in serum creatinine ≥ 50% after the six cycles of chemotherapy, respectively. Results: Acute cisplatin nephropathy occurred in 23 of 124, 8 of 110, 6 of 92, 10 of 68, 7 of 59, and 7 of 45 patients after the 1st to 6th cycle of chemotherapy, respectively. In all, 51 patients (51.5%) experienced acute cisplatin nephropathy. Chronic cisplatin nephropathy occurred in 25 out of 45 patients (55.5%). The occurrence of chronic cisplatin nephropathy was significantly associated with that of acute cisplatin nephropathy (p<0.01). In chronic cisplatin nephropathy, the serum creatinine increased to 1.82±1.18 mg/dL from the basal 0.82±0.11 mg/dL (p<0.01). It was 1.60±1.05 mg/dL at the end of the follow-up period (112±90 days). Conclusions: Despite prophylactic hydration, the incidence of cisplatin nephropathy in patients with lung cancer is still high. Acute cisplatin nephropathy may predispose patients to chronic cisplatin nephropathy, but the latter does not seem to be progressive. (Korean J Med 78:341-347, 2010)

참고문헌 (Reference)

1 김석영, "방사선 조영제에 의한 급성 신장 손상의 예방" 대한신장학회 26 (26): 657-659, 2007

2 de Jongh FE, "Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients" 88 : 1199-1206, 2003

3 Fjeldborg P, "The long-term effect of cisplatin on renal function" 58 : 2214-2217, 1986

4 Hamilton CR, "The late effects of cis-platinum on renal function" 25 : 185-189, 1989

5 Haas A, "The influence of aminoglycosides on the nephrotoxicity of cis-diamminedichloroplatinum in cancer patients" 147 : 363-, 1983

6 Blachley JD, "Renal and electrolyte disturbances associated with cisplatin" 95 : 628-632, 1981

7 Launay-Vacher V, "Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care" 61 : 903-909, 2008

8 Rossof AH, "Preliminary clinical experience with cis-diamminedichloroplatinum (II) (NSC 119875, CACP)" 30 : 1451-1456, 1972

9 Hargis JB, "Predicting genitourinary toxicity in patients receiving cisplatin-based combination chemotherapy: a Cancer and Leukemia Group B study" 30 : 291-296, 1992

10 Jongejan HT, "Potentiation of cis-diamminedichloroplatinum nephrotoxicity by amikacin in rats" 22 : 178-180, 1988

11 Madias NE, "Platinum nephrotoxicity" 65 : 307-314, 1978

12 Kedar A, "Peripheral neuropathy as a complication of cis-dichlorodiammineplatinum(II) treatment: a case report" 62 : 819-821, 1978

13 Fleming S, "Ototoxicity from cis-platinum in patients with stages III and IV previously untreated squamous cell cancer of the head and neck" 8 : 302-306, 1985

14 Cornelison TL, "Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin" 50 : 147-158, 1993

15 Brillet G, "Long-term renal effect of cisplatin in man" 14 : 81-84, 1994

16 Hansen SW, "Long-term effects on renal function and blood pressure of treatment with cisplatin, vinblastine, and bleomycin in patients with germ cell cancer" 6 : 1728-1731, 1988

17 Merouani A, "Increased nephrotoxicity of combination taxol and cisplatin chemotherapy in gynecologic cancers as compared to cisplatin alone" 17 : 53-58, 1997

18 Cvitkovic E, "Improvement of cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model" 39 : 1357-1361, 1977

19 Jorkasky DK, "Drug-induced tubulo-interstitial nephritis: special cases" 8 : 62-71, 1988

20 최영환, "Cisplatin의 신독성에 관한 연구" 32 : 410-422, 1987

21 Pabla N, "Cisplatin nephrotoxicity: mechanisms and renoprotective strategies" 73 : 994-1007, 2008

22 Daugaard G, "Cisplatin nephrotoxicity: experimental and clinical studies" 37 : 1-12, 1990

23 Arany I, "Cisplatin nephrotoxicity" 23 : 460-464, 2003

24 Groth S, "Acute and long-term nephrotoxicity of cis-platinum in man" 17 : 191-196, 1986

25 Levey AS, "A simplified equation to predict glomerular filtration rate from serum creatinine [Abstract]" 11 : 115A-, 2000